These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9875590)

  • 1. Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir.
    Karmochkine M; Raguin G
    AIDS; 1998 Dec; 12(18):2499. PubMed ID: 9875590
    [No Abstract]   [Full Text] [Related]  

  • 2. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s.
    Henry K; Kitch D; Dube M; Zackin R; Parker RA; Sprecher D; Hammer S; Currier J;
    AIDS; 2004 Dec; 18(18):2434-7. PubMed ID: 15622323
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipidemia in patients with HIV infection treated with protease inhibitors].
    López García F; Mora Rufete A; Escolano Hortelano CM; Gutiérrez Rodero F
    Rev Clin Esp; 1999 Nov; 199(11):780-1. PubMed ID: 10638253
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe hypertension and renal atrophy associated with indinavir.
    Cattelan AM; Trevenzoli M; Naso A; Meneghetti F; Cadrobbi P
    Clin Infect Dis; 2000 Mar; 30(3):619-21. PubMed ID: 10722466
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired reactive perforating collagenosis induced by indinavir in 2 patients with HIV disease.
    Calista D; Morri M
    Eur J Dermatol; 2008; 18(1):84-5. PubMed ID: 18086600
    [No Abstract]   [Full Text] [Related]  

  • 6. Indinavir and thrombocytopenia.
    Durand JM
    AIDS; 1999 Jan; 13(1):148-9. PubMed ID: 10207566
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.
    Malavaud B; Dinh B; Bonnet E; Izopet J; Payen JL; Marchou B
    Antivir Ther; 2000 Mar; 5(1):3-5. PubMed ID: 10846585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myocardial infarct and severe angina after antiproteases: 4 cases].
    Hassoun S; Pisanté L; Cattan S; Nallet O; Jarousse B; Jeantils V; Rosenheim M; Zemour G; Fauvelle F
    Therapie; 2000; 55(3):399-402. PubMed ID: 10967720
    [No Abstract]   [Full Text] [Related]  

  • 9. Indinavir-induced cholelithiasis in a patient infected with human immunodeficiency virus.
    Verdon R; Daudon M; Albessard F; Brefort JL; Bazin C
    Clin Infect Dis; 2002 Sep; 35(5):e57-9. PubMed ID: 12173151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indinavir--effect on sugar and insulin.
    TreatmentUpdate; 2001 Jun; 13(2):7-8. PubMed ID: 11570290
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nephrolithiasis in a HIV infected patient treated with indinavir].
    Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Myśliwiec M
    Przegl Lek; 2001; 58(6):528-9. PubMed ID: 11816748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The choice of HIV protease inhibitor: indinavir is currently the best option.
    Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lopinavir/ritonavir- and indinavir-induced thrombocytopenia in a patient with HIV infection.
    Colebunders R; De Schacht C; Vanwolleghem T; Callens S
    Int J Infect Dis; 2004 Sep; 8(5):315-6. PubMed ID: 15325601
    [No Abstract]   [Full Text] [Related]  

  • 14. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
    Manfredi R; Chiodo F
    J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indinavir-induced nephropathy.
    Grabe DW; Eisele G; Miller C; Singh J; Stein D
    Clin Nephrol; 1999 Mar; 51(3):181-3. PubMed ID: 10099891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indinavir and bones: does thickness = strength?
    TreatmentUpdate; 2001 Jul; 13(3):6-8. PubMed ID: 11569990
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indinavir-associated tubulointerstitial renal disease].
    Gagnon RF; Mehio A; Iqbal S; Tsoukas CM
    Nephrol Ther; 2007 Dec; 3(7):461-2. PubMed ID: 18048001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor.
    Carr A; Cooper DA
    N Engl J Med; 1998 Oct; 339(18):1296. PubMed ID: 9791146
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipodystrophy and 'buffalo hump' during treatment with HIV protease inhibitors].
    Dieleman JP; Hillebrand-Haverkort ME; van der Ende ME; Sturkenboom MC; Lange JM; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2856-60. PubMed ID: 10065260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir.
    Benesic A; Zilly M; Kluge F; Weissbrich B; Winzer R; Klinker H; Langmann P
    Infection; 2004 Aug; 32(4):229-33. PubMed ID: 15293079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.